Patients with minimal hepatic encephalopathy show impaired mismatch negativity correlating with reduced performance
Vicente Felipo1, Juan F Ordoño, Amparo Urios
1Laboratory of Neurobiology, Centro Investigación Príncipe Felipe, Valencia, Spain.
Unlabelled:
Attention deficit is an early event in the cognitive impairment of patients with minimal hepatic encephalopathy (MHE). The underlying mechanisms remain unclear. Mismatch negativity (MMN) is an auditory event-related potential that reflects an attentional trigger. Patients with schizophrenia show impaired attention and cognitive function, which are reflected in altered MMN. We hypothesized that patients with MHE, similarly to those with schizophrenia, should show MMN alterations related with attention deficits. The aims of this work were to assess whether (1) MMN is altered in cirrhotic patients with MHE, compared to those without MHE, (2) MMN changes in parallel with performance in attention tests and/or MHE in a longitudinal study, and (3) MMN predicts performance in attention tests and/or in the Psychometric Hepatic Encephalopathy Score (PHES). We performed MMN analysis as well as attention and coordination tests in 34 control subjects and in 37 patients with liver cirrhosis without MHE and 23 with MHE. Patients with MHE show reduced performance in selective and sustained attention tests and in visuomotor and bimanual coordination tests. The MMN wave area was reduced in patients with MHE, but not in those without MHE. In the longitudinal study, MMN area improved in parallel with performance in attention tests and PHES in 4 patients and worsened in parallel in another 4. Logistic regression analyses showed that MMN area predicts performance in attention tests and in PHES, but not in other tests or critical flicker frequency. Receiver operating characteristic curve analyses showed that MMN area predicts attention deficits in the number connection tests A and B, Stroop tasks, and MHE, with sensitivities of 75%-90% and specificities of 76%-83%.
Conclusion:
MMN area is useful to diagnose attention deficits and MHE in patients with liver cirrhosis.
Insights
Mismatch negativity (MMN) alterations are linked to attention deficits in minimal hepatic encephalopathy (MHE). MMN wave area can help diagnose attention deficits and MHE in liver cirrhosis patients.
Area of Science:
- Neuroscience
- Hepatology
- Cognitive Science
Background:
- Attention deficits are an early cognitive impairment in minimal hepatic encephalopathy (MHE).
- The mechanisms underlying MHE-related attention deficits are not fully understood.
- Mismatch negativity (MMN), an auditory event-related potential, reflects attentional processes and is altered in conditions like schizophrenia.
Purpose of the Study:
- To investigate MMN alterations in cirrhotic patients with MHE compared to those without MHE.
- To determine if MMN changes correlate with attention test performance and MHE status longitudinally.
- To assess the predictive value of MMN for attention deficits and MHE severity.
Main Methods:
- MMN analysis, attention tests, and coordination tests were performed on control subjects, cirrhotic patients without MHE, and cirrhotic patients with MHE.
- Longitudinal assessment of MMN and cognitive performance in a subset of patients.
- Logistic regression and receiver operating characteristic (ROC) curve analyses were used to evaluate MMN's predictive capabilities.
Main Results:
- Patients with MHE exhibited reduced performance in attention and coordination tests.
- A reduced MMN wave area was observed in patients with MHE, but not in those without MHE.
- MMN area changes paralleled improvements or worsening in attention tests and Psychometric Hepatic Encephalopathy Score (PHES) in a longitudinal study.
- MMN area significantly predicted performance in attention tests (Number Connection Tests A and B, Stroop tasks) and PHES, with high sensitivity and specificity.
Conclusions:
- Reduced MMN wave area is a characteristic finding in cirrhotic patients with MHE.
- MMN serves as a valuable diagnostic tool for identifying attention deficits and MHE in liver cirrhosis.
- MMN has potential as a biomarker for cognitive impairment in MHE.
Related Concept Videos
Hepatic Encephalopathy
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test


